Overview

Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents

Status:
Completed

Trial end date:
2010-12-03

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of a range of doses of oral sumatriptan for the acute treatment of migraine in children ages 10 to 17.

Phase:

Phase 3

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Sumatriptan